nr-20250930

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-02960

NPK International Inc.

(Exact name of registrant as specified in its charter)


Delaware		72-1123385
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

9320 Lakeside Boulevard,	Suite 100
The Woodlands,	Texas	77381
(Address of principal executive offices)		(Zip Code)

(281) 362-6800

(Registrant’s telephone number, including area code)


Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value	NPKI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☑

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☑

As of October 29, 2025, a total of 84,494,699 shares of common stock, $0.01 par value per share, were outstanding.

NPK INTERNATIONAL INC.

INDEX TO QUARTERLY REPORT ON FORM 10-Q

FOR THE THREE AND NINE MONTHS ENDED

SEPTEMBER 30, 2025


PART I	FINANCIAL INFORMATION	2
ITEM 1.	Financial Statements	2
	Condensed Consolidated Balance Sheets	2
	Condensed Consolidated Statements of Operations	3
	Condensed Consolidated Statements of Comprehensive Income (Loss)	4
	Condensed Consolidated Statements of Stockholders’ Equity	5
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	24
ITEM 4.	Controls and Procedures	24
PART II	OTHER INFORMATION	25
ITEM 1.	Legal Proceedings	25
ITEM 1A.	Risk Factors	25
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	25
ITEM 3.	Defaults Upon Senior Securities	26
ITEM 4.	Mine Safety Disclosures	26
ITEM 5.	Other Information	26
ITEM 6.	Exhibits	27
	Signatures	28

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. We also may provide oral or written forward-looking statements in other materials we release to the public. Words such as “will,” “may,” “could,” “would,” “should,” “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” and similar expressions are intended to identify these forward-looking statements but are not the exclusive means of identifying them. These forward-looking statements reflect the current views of our management as of the filing date of this Quarterly Report on Form 10-Q; however, various risks, uncertainties, contingencies, and other factors, some of which are beyond our control, are difficult to predict and could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, these statements.

We assume no obligation to update, amend, or clarify publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed in this Quarterly Report on Form 10-Q might not occur.

For further information regarding these and other factors, risks, and uncertainties that could cause actual results to differ, we refer you to the risk factors set forth in Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024.

PART I FINANCIAL INFORMATION

ITEM 1. Financial Statements

NPK International Inc.

Condensed Consolidated Balance Sheets

(Unaudited)


(In thousands, except share data)	September 30, 2025		December 31, 2024
ASSETS
Cash and cash equivalents	$	35,636	$	17,756
Receivables, net of allowance of $349 and $948, respectively	57,362		74,841
Inventories	9,668		14,659
Prepaid expenses and other current assets	5,152		5,728
Total current assets	107,818		112,984

Property, plant and equipment, net	210,521		187,483
Operating lease assets	10,840		11,793
Goodwill	47,481		47,222
Other intangible assets, net	8,868		10,331
Deferred tax assets	6,844		15,593
Other assets	12,087		8,276
Total assets	$	404,459	$	393,682

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current debt	$	3,636	$	2,900
Accounts payable	21,960		19,459
Accrued liabilities	23,392		22,300
Total current liabilities	48,988		44,659

Long-term debt, less current portion	5,906		4,827
Noncurrent operating lease liabilities	9,649		10,896
Deferred tax liabilities	1,820		1,203
Other noncurrent liabilities	4,173		5,602
Total liabilities	70,536		67,187

Commitments and contingencies (Note 10)

Common stock, $0.01 par value (200,000,000 shares authorized and 111,669,464 and 111,669,464 shares issued, respectively)	1,117		1,117
Paid-in capital	630,802		633,239
Accumulated other comprehensive loss	(2,668)		(2,871)
Retained earnings (deficit)	(115,131)		(139,466)
Treasury stock, at cost (27,178,065 and 25,114,978 shares, respectively)	(180,197)		(165,524)
Total stockholders’ equity	333,923		326,495
Total liabilities and stockholders’ equity	$	404,459	$	393,682

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

NPK International Inc.

Condensed Consolidated Statements of Operations

(Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands, except per share data)	2025		2024		2025		2024
Revenues	$	68,838	$	44,207	$	201,848	$	159,965
Cost of revenues	46,870		32,067		129,449		105,358
Selling, general and administrative expenses	13,279		11,005		38,682		35,335
Other operating (income) loss, net	(368)		(99)		(497)		(1,435)
Operating income from continuing operations	9,057		1,234		34,214		20,707

Foreign currency exchange (gain) loss	31		(562)		(909)		170
Interest (income) expense, net	(47)		943		(94)		2,612
Income from continuing operations before income taxes	9,073		853		35,217		17,925

Provision (benefit) for income taxes from continuing operations	3,010		(14,016)		9,995		(9,626)
Income from continuing operations	6,063		14,869		25,222		27,551
Loss from discontinued operations	(409)		(189,167)		(887)		(186,516)
Net income (loss)	$	5,654	$	(174,298)	$	24,335	$	(158,965)

Income (loss) per common share - basic:
Income from continuing operations	$	0.07	$	0.17	$	0.30	$	0.32
Loss from discontinued operations	—		(2.19)		(0.01)		(2.18)
Net income (loss)	$	0.07	$	(2.02)	$	0.29	$	(1.86)

Income (loss) per common share - diluted:
Income from continuing operations	$	0.07	$	0.17	$	0.29	$	0.32
Loss from discontinued operations	—		(2.16)		(0.01)		(2.13)
Net income (loss)	$	0.07	$	(1.99)	$	0.28	$	(1.82)

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

NPK International Inc.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
(In thousands)	2025		2024		2025		2024
Net income (loss)	$	5,654	$	(174,298)	$	24,335	$	(158,965)
Foreign currency translation adjustments, net of tax benefit (expense) of $0, $0, $0, $111	(166)		3,849		203		604
Recognition of Fluids Systems cumulative foreign currency translation losses	—		59,469		—		59,469
Comprehensive income (loss)	$	5,488	$	(110,980)	$	24,538	$	(98,892)

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

NPK International Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(Unaudited)


(In thousands)	Common Stock		Paid-In Capital		Accumulated Other Comprehensive Loss		Retained Earnings (Deficit)		Treasury Stock		Total
Balance at June 30, 2025	$	1,117	$	629,952	$	(2,502)	$	(120,785)	$	(178,947)	$	328,835
Net income	—		—		—		5,654		—		5,654
Employee stock options, restricted stock and employee stock purchase plan	—		(691)		—		—		2,188		1,497
Stock-based compensation expense	—		1,541		—		—		—		1,541
Treasury shares purchased at cost	—		—		—		—		(3,438)		(3,438)
Foreign currency translation, net of tax	—		—		(166)		—		—		(166)
Balance at September 30, 2025	$	1,117	$	630,802	$	(2,668)	$	(115,131)	$	(180,197)	$	333,923

Balance at June 30, 2024	$	1,117	$	631,497	$	(66,084)	$	26,137	$	(166,058)	$	426,609
Net loss	—		—		—		(174,298)		—		(174,298)
Employee stock options, restricted stock and employee stock purchase plan	—		(329)		—		—		157		(172)
Stock-based compensation expense	—		997		—		—		—		997
Treasury shares purchased at cost	—		—		—		—		—		—
Foreign currency translation, net of tax	—		—		3,849		—		—		3,849
Recognition of Fluids Systems cumulative foreign currency translation losses	—		—		59,469		—		—		59,469
Balance at September 30, 2024	$	1,117	$	632,165	$	(2,766)	$	(148,161)	$	(165,901)	$	316,454

Balance at December 31, 2024	$	1,117	$	633,239	$	(2,871)	$	(139,466)	$	(165,524)	$	326,495
Net income	—		—		—		24,335		—		24,335
Employee stock options, restricted stock and employee stock purchase plan	—		(6,574)		—		—		5,977		(597)
Stock-based compensation expense	—		4,137		—		—		—		4,137
Treasury shares purchased at cost	—		—		—		—		(20,650)		(20,650)
Foreign currency translation, net of tax	—		—		203		—		—		203
Balance at September 30, 2025	$	1,117	$	630,802	$	(2,668)	$	(115,131)	$	(180,197)	$	333,923

Balance at December 31, 2023	$	1,117	$	639,645	$	(62,839)	$	10,773	$	(173,332)	$	415,364
Net loss	—		—		—		(158,965)		—		(158,965)
Employee stock options, restricted stock and employee stock purchase plan	—		(11,599)		—		31		7,476		(4,092)
Stock-based compensation expense	—		4,119		—		—		—		4,119
Treasury shares purchased at cost	—		—		—		—		(45)		(45)
Foreign currency translation, net of tax	—		—		604		—		—		604
Recognition of Fluids Systems cumulative foreign currency translation losses	—		—		59,469		—		—		59,469
Balance at September 30, 2024	$	1,117	$	632,165	$	(2,766)	$	(148,161)	$	(165,901)	$	316,454

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

NPK International Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)


	Nine Months Ended September 30,
(In thousands)	2025		2024
Cash flows from operating activities:
Net income (loss)	$	24,335	$	(158,965)
Adjustments to reconcile net income (loss) to net cash provided by operations:
Loss on divestitures	—		195,729
Depreciation and amortization	18,235		21,804
Stock-based compensation expense	4,137		4,119
Provision for deferred income taxes	9,362		(22,290)
Credit loss expense	19		998
Gain on sale of assets	(2,203)		(2,412)
Gain on insurance recovery	—		(874)
Amortization of original issue discount and debt issuance costs	394		885
Change in assets and liabilities:
Increase in receivables	(2,462)		(13,734)
Decrease in inventories	5,007		9,481
Increase in other assets	(3,711)		(1,027)
Increase in accounts payable	1,466		12,498
Increase (decrease) in accrued liabilities and other	405		(3,916)
Net cash provided by operating activities	54,984		42,296

Cash flows from investing activities:
Capital expenditures	(34,419)		(29,940)
Proceeds from divestitures, net of cash disposed	14,485		48,499
Proceeds from sale of property, plant and equipment	3,819		3,188
Proceeds from insurance property claim	—		1,385
Other investing activities	3,089		—
Net cash provided by (used in) investing activities	(13,026)		23,132

Cash flows from financing activities:
Borrowings on lines of credit	—		177,541
Payments on lines of credit	—		(224,292)
Debt issuance costs	(811)		(50)
Purchases of treasury stock	(22,695)		(4,504)
Proceeds from employee stock plans	1,497		17
Other financing activities	(2,639)		(9,538)
Net cash used in financing activities	(24,648)		(60,826)

Effect of exchange rate changes on cash	91		(119)

Net increase in cash, cash equivalents, and restricted cash	17,401		4,483
Cash, cash equivalents, and restricted cash at beginning of period	18,237		38,901
Cash, cash equivalents, and restricted cash at end of period	$	35,638	$	43,384

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

NPK INTERNATIONAL INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 – Basis of Presentation and Significant Accounting Policies

NPK International Inc. is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. We previously operated a Fluids Systems business which was exited upon the sale of the business in September 2024 (as further described below).

The accompanying unaudited condensed consolidated financial statements of NPK International Inc. and our wholly-owned subsidiaries, which we collectively refer to as “NPK,” the “Company,” “we,” “our,” or “us,” have been prepared in accordance with Rule 10-01 of Regulation S-X for interim financial statements required to be filed with the Securities and Exchange Commission, and do not include all information and footnotes required by the accounting principles generally accepted in the United States (“U.S. GAAP”) for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024. Our fiscal year end is December 31, our third quarter represents the three-month period ended September 30, and our first nine months represents the nine-month period ended September 30. The results of operations for the third quarter and first nine months of 2025 are not necessarily indicative of the results to be expected for the entire year. Unless otherwise noted, all currency amounts are stated in U.S. dollars.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of September 30, 2025, our results of operations for the third quarter and first nine months of 2025 and 2024, and our cash flows for the first nine months of 2025 and 2024. All adjustments are of a normal recurring nature. Our balance sheet at December 31, 2024 is derived from the audited consolidated financial statements at that date.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. For further information, see Note 1 in our Annual Report on Form 10-K for the year ended December 31, 2024.

Our business provides temporary worksite access solutions, including the rental of our recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. We also sell our manufactured recyclable composite mats to customers around the world, with power transmission being the primary end market.

We previously operated a Fluids Systems business, which was historically reported as a separate operating segment, that provided drilling and completion fluids products and related technical services to customers for oil, natural gas, and geothermal projects primarily in Europe, the Middle East and Africa, and North America, as well as certain countries in Asia Pacific. On September 13, 2024, we completed the sale of substantially all of the Company’s Fluids Systems segment (the “Sale Transaction”) to SCF Partners (the “Purchaser”). The results of operations of Fluids Systems are reported in discontinued operations in the consolidated statements of operations. All results and information in the consolidated financial statements and related notes are presented for our continuing operations and exclude Fluids Systems unless otherwise noted specifically as discontinued operations. See Note 2 for additional information.

New Accounting Pronouncements

Standards Not Yet Adopted

Income Taxes: Improvements to Income Tax Disclosures. In December 2023, the FASB issued new guidance intended to enhance the transparency and decision usefulness of income tax disclosures. This guidance is effective for us for the year ending December 31, 2025. These requirements are not expected to have an impact on our consolidated financial statements but will impact our income tax disclosures.

Disaggregation of Income Statement Expenses. In November 2024, the FASB issued new guidance which requires entities to disclose additional information about specific expense categories, such as employee compensation and depreciation. This guidance will be effective for us for years beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with early adoption permitted on either a prospective or retrospective basis. We are currently evaluating the impact of the new guidance on our consolidated financial statements and related disclosures.

Note 2 – Discontinued Operations

Sale of Fluids Systems Business

As discussed above in Note 1 and more fully described in Note 2 in our Annual Report on Form 10-K for the year ended December 31, 2024, on September 13, 2024, we completed the Sale Transaction. In connection with the Sale Transaction in the third quarter of 2024, we received $48.5 million in cash proceeds, net of cash disposed, and recognized a pre-tax loss on sale of $195.7 million, which included a $59.5 million non-cash charge for the reclassification of cumulative foreign currency translation losses related to the Fluids Systems business.

As of September 30, 2025 and December 31, 2024, approximately $3.6 million and $18.0 million, respectively, of net assets were included in the consolidated balance sheets, reflecting receivables and deferred consideration due from the Purchaser net of estimated liabilities due to the Purchaser.

Net assets related to the Sale Transaction consisted of the following:


(In thousands)	September 30, 2025		December 31, 2024
Receivables due from the Purchaser	$	313	$	15,978
Estimated deferred consideration due from the Purchaser	3,591		3,550
Note receivable due from the Purchaser	5,000		5,000
Estimated liabilities due to the Purchaser	(5,308)		(6,488)
Net assets due from the Purchaser	$	3,596	$	18,040

Receivables due from the Purchaser primarily reflects additional consideration for the actual working capital delivered at closing, of which $15.6 million was received in the first half of 2025. Estimated deferred consideration due from the Purchaser reflects certain pre-closing tax assets and other receivables that are expected to be substantially realized in the fourth quarter of 2025. The note receivable due from the Purchaser matures in March 2030 and bears interest at a rate of 12.5% per year. The receivables and deferred consideration due from the Purchaser are included in other receivables and the note receivable due from the Purchaser is included in other noncurrent assets in the consolidated balance sheet.

Estimated liabilities due to the Purchaser includes certain payables for pre-closing tax liabilities and obligations attributable to the Fluids Systems business that are expected to be substantially settled in 2025, as well as an estimated liability for contractual indemnifications related to various pre-closing contingencies of the Fluids Systems business. These estimated liabilities due to the Purchaser are included in accrued liabilities and other noncurrent liabilities in the consolidated balance sheet.

Our estimates for the fair value of deferred consideration due from the Purchaser and liabilities due to the Purchaser may change and any income or expense associated with such changes will be presented in discontinued operations.

The criteria for discontinued operations presentation were met during the third quarter of 2024, and consequently, the results of the former Fluids Systems segment are reported as income (loss) from discontinued operations within the consolidated statements of operations for all periods presented. We elected not to adjust the consolidated statements of cash flows to separately present cash flows attributable to discontinued operations. Accordingly, we have disclosed the depreciation, capital expenditures and significant operating and investing non-cash items related to discontinued operations below.

The following table summarizes the significant items included in income (loss) from discontinued operations in the condensed consolidated statements of operations.


	Third Quarter				First Nine Months
(In thousands)	2025		2024		2025		2024
Revenues	$	—	$	102,944	$	—	$	335,302
Cost of revenues	—		89,102		—		290,482
Selling, general and administrative expenses	596		11,273		1,044		37,668
Other operating (income) loss, net	—		(345)		—		(1,447)
Operating income (loss) from discontinued operations	(596)		2,914		(1,044)		8,599

Foreign currency exchange (gain) loss	34		1,529		168		894
Interest (income) expense, net	(37)		756		(29)		2,633
Income (loss) from discontinued operations before income taxes	(593)		629		(1,183)		5,072

Loss on sale of discontinued operations before income taxes	—		(195,729)		—		(195,729)
Benefit for income taxes from discontinued operations	(184)		(5,933)		(296)		(4,141)
Loss from discontinued operations	$	(409)	$	(189,167)	$	(887)	$	(186,516)

For the first nine months of 2025 and 2024, significant operating and investing items related to the former Fluids Systems segment were as follows:


	First Nine Months
(In thousands)	2025		2024
Operating activities of discontinued operations:
Depreciation and amortization	$	—	$	4,872

Investing activities of discontinued operations:
Capital expenditures	$	—	$	3,645

Note 3 – Earnings Per Share

The following table presents the reconciliation of the numerator and denominator for calculating net income (loss) per share:


	Third Quarter				First Nine Months
(In thousands, except per share data)	2025		2024		2025		2024
Numerator
Income from continuing operations	$	6,063	$	14,869	$	25,222	$	27,551
Loss from discontinued operations	(409)		(189,167)		(887)		(186,516)
Net income (loss)	$	5,654	$	(174,298)	$	24,335	$	(158,965)

Denominator
Weighted average common shares outstanding - basic	84,359		86,377		84,959		85,619
Dilutive effect of restricted stock awards and stock options	707		1,113		862		1,834
Weighted average common shares outstanding - diluted	85,066		87,490		85,821		87,453

Income (loss) per common share - basic:
Income from continuing operations	$	0.07	$	0.17	$	0.30	$	0.32
Loss from discontinued operations	—		(2.19)		(0.01)		(2.18)
Net income (loss)	$	0.07	$	(2.02)	$	0.29	$	(1.86)

Income (loss) per common share - diluted:
Income from continuing operations	$	0.07	$	0.17	$	0.29	$	0.32
Loss from discontinued operations	—		(2.16)		(0.01)		(2.13)
Net income (loss)	$	0.07	$	(1.99)	$	0.28	$	(1.82)

We excluded the following weighted-average potential shares from the calculations of diluted net income (loss) per share during the applicable periods because their inclusion would have been anti-dilutive for continuing operations:


	Third Quarter		First Nine Months
(In thousands)	2025	2024	2025	2024
Restricted stock awards and stock options	—	330	343	399

Note 4 – Repurchase Program

Our Board of Directors has authorized a securities repurchase program available for repurchases of our common stock. On April 30, 2025, our Board of Directors increased the remaining authorization under the repurchase program to $100.0 million.

Our repurchase program authorizes us to purchase outstanding shares of our common stock in the open market or as otherwise determined by management, subject to certain limitations under the Credit Facility (as defined in Note 8) and other factors. The repurchase program has no specific term. Repurchases are expected to be funded from operating cash flows and available cash on hand. As part of the share repurchase program, our management has been authorized to establish trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934.

During the first nine months of 2025, we repurchased an aggregate of 3.0 million shares of our common stock under the repurchase program for a cost of $20.4 million. Due to restrictions associated with the Fluids Systems sale process and other events, no shares of common stock were repurchased under the repurchase program during the first nine months of 2024.

As of September 30, 2025, we had $91.7 million remaining under the program.

Note 5 – Stock-Based and Other Long-Term Incentive Compensation

During the second quarter of 2025, the Compensation Committee of our Board of Directors (“Compensation Committee”) approved equity-based compensation awards to executive officers and other key employees consisting of an aggregate of 0.6 million restricted stock units, which will vest in equal installments over a three-year period. In addition, non-

employee directors received grants of an aggregate of 0.1 million restricted stock awards, which will vest in full on the earlier of the day prior to the next annual meeting of stockholders following the grant date or the first anniversary of the grant date. The weighted average grant-date fair value was $8.45 per share for the restricted stock units and $8.28 per share for the restricted stock awards. At September 30, 2025, 3.0 million shares remained available for award under the 2015 Plan and 0.3 million shares remained available for awards under the 2014 Director Plan.

Also, during the second quarter of 2025, the Compensation Committee approved the issuance of 0.4 million performance-based restricted stock units to certain executive officers with the payout of shares for each executive ranging from 0% to 200% of target. The performance-based restricted stock units will be settled in shares of common stock, with 70% to be settled based on the relative ranking of the Company’s total shareholder return (“TSR”) as compared to the TSR of a designated peer group and 30% to be settled based on the Company’s consolidated return on net capital employed (“RONCE”), each measured over a three-year performance period. TSR performance for the 2025 grants will be determined based on the Company’s and peer group’s average closing share price for the 30-calendar day period ending May 31, 2028, adjusted for dividends, as compared to the 30-calendar day period ending June 1, 2025. RONCE performance for the 2025 grants will be determined based on the Company’s average three-year RONCE performance for the fiscal years ending December 31, 2025, 2026 and 2027.

The TSR portion of the performance-based restricted stock units had a grant-date fair value of $11.57 per share using a Monte-Carlo valuation model, which will be recognized ratably over the service period. Assumptions used in the model included a risk-free interest rate of 4.0%, an expected life of 3 years, and an expected volatility of 49.8%. The RONCE portion of the performance-based restricted stock units had a grant-date fair value of $8.45 per share, which will be recognized ratably over the service period using the probable number of shares expected to vest based on the RONCE performance condition.

Note 6 – Receivables

Receivables consisted of the following:


(In thousands)	September 30, 2025		December 31, 2024
Trade receivables:
Gross trade receivables	$	49,653	$	46,819
Allowance for credit losses	(349)		(948)
Net trade receivables	49,304		45,871
Income tax receivables	1,681		2,049
Other receivables	6,377		26,921
Total receivables, net	$	57,362	$	74,841

Other receivables as of September 30, 2025 and December 31, 2024 included $4.1 million and $23.2 million, respectively, for amounts due from the Purchaser, including the receivables and estimated deferred consideration related to the Sale Transaction (see Note 2) as well as amounts due under the transition services agreement. Other receivables as of September 30, 2025 and December 31, 2024 also included an insurance receivable of $0.3 million and $1.7 million related to a cybersecurity event.

Changes in our allowance for credit losses were as follows:


	First Nine Months
(In thousands)	2025		2024
Balance at beginning of period	$	948	$	1,223
Credit loss expense	19		80
Write-offs, net of recoveries	(618)		(38)
Balance at end of period	$	349	$	1,265

Note 7 – Inventories

Inventories consisted of the following:


(In thousands)	September 30, 2025		December 31, 2024
Raw materials	$	4,803	$	5,721
Finished goods	4,865		8,938
Total inventories	$	9,668	$	14,659

Raw materials consist primarily of resins and other materials used to manufacture composite mats, as well as materials that are consumed in providing spill containment and other services to our customers. Finished goods consist primarily of our composite mats.

Note 8 – Financing Arrangements and Fair Value of Financial Instruments

Financing arrangements consisted of the following:


	September 30, 2025						December 31, 2024
(In thousands)	Principal Amount		Unamortized Discount and Debt Issuance Costs		Total Debt		Principal Amount		Unamortized Discount and Debt Issuance Costs		Total Debt
Credit Facility	$	—	$	—	$	—	$	—	$	—	$	—
Amended ABL Facility	—		—		—		—		—		—
Finance leases	9,537		—		9,537		7,622		—		7,622
Other debt	5		—		5		106		(1)		105
Total debt	9,542		—		9,542		7,728		(1)		7,727
Less: current portion	(3,636)		—		(3,636)		(2,900)		—		(2,900)
Long-term debt	$	5,906	$	—	$	5,906	$	4,828	$	(1)	$	4,827

Credit Facility. On June 20, 2025, we entered into a U.S. senior secured revolving credit agreement (the “Credit Facility”) with a group of lenders that provides financing of up to $150 million available for borrowings (inclusive of letters of credit), which can be increased up to $250 million, subject to certain conditions. The Credit Facility and the loans made under the Credit Facility are secured by a first priority lien on substantially all of the personal property of the Company and its significant U.S. subsidiaries as guarantors (subject to customary exceptions and exclusions). The Credit Facility will mature on June 20, 2030. The Credit Facility replaced the Amended ABL Facility (as defined below).

As of September 30, 2025, we had no outstanding borrowings and $5.7 million in outstanding letters of credit, resulting in $144.3 million of remaining availability under the Credit Facility.

Under the terms of the Credit Facility, we may elect to borrow at a variable interest rate based on either the Term SOFR rate or an alternate base rate plus, in each case, a per annum applicable margin. The applicable margin will range from 1.75% to 2.25% for Term SOFR loans and 0.75% to 1.25% for alternate base rate loans, based on the consolidated leverage ratio (as defined in the Credit Facility) as of the last day of the most recent fiscal quarter. We are also required to pay a commitment fee on the unused portion of the Credit Facility ranging from 0.25% to 0.35% per annum based on the consolidated leverage ratio.

As of September 30, 2025, the applicable margin for loans under the Credit Facility was 1.75% for Term SOFR loans and 0.75% for alternate base rate loans, and the applicable commitment fee was 0.25% per annum.

The Credit Facility requires compliance with a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio, each as defined in the Credit Facility. In addition, at our option, we may choose to increase the maximum consolidated leverage ratio for a certain period following a significant acquisition, subject to certain limitations, as defined in the Credit Facility. As of September 30, 2025, we were in compliance with required ratios.

The Credit Facility contains various customary representations, warranties and covenants that, among other things and subject to certain specified circumstances and exceptions, restrict or limit the ability of the Company and its subsidiaries to incur indebtedness (including guarantees), grant liens, make investments, pay dividends or distributions with respect to capital stock or make other restricted payments, make prepayments on other indebtedness, engage in mergers or other fundamental changes, dispose of property, or change the nature of their business.

The Credit Facility includes various events of default (subject to certain materiality thresholds and/or grace periods), including non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations or warranties, cross-default to other material indebtedness, bankruptcy and insolvency events, invalidity or impairment of guarantees or security interests or invalidity of loan documents, certain ERISA events, unsatisfied or unstayed judgments and change of control.

Asset-Based Loan Facility. Our U.S. asset-based revolving credit agreement, as amended and restated in September 2024 (the “Amended ABL Facility”) provided financing of up to $100 million available for borrowings (inclusive of letters of credit), with a term expiring May 2027. We terminated the Amended ABL Facility in June 2025 and replaced it with the Credit Facility, as described above. As of the date of termination, we had no outstanding borrowings under the Amended ABL Facility. In the second quarter of 2025, we recognized a charge of $0.2 million in interest expense for the write-off of debt issuance costs in connection with the termination of the Amended ABL Facility.

Other Financing Arrangements. We also maintain finance leases primarily related to transportation equipment. During the first nine months of 2025, we entered into $4.4 million of new finance lease liabilities in exchange for leased assets.

In addition, at September 30, 2025, we had $9.5 million in outstanding letters of credit (inclusive of the amount outstanding under the Credit Facility as described above), performance bonds, and other guarantees.

Interest income, net of $94 thousand for the first nine months of 2025 includes interest income of $1.5 million, net of interest expense of $1.4 million.

Fair Value of Financial Instruments. Our financial instruments include cash and cash equivalents, receivables, payables, a

SEC Form 10-Q filed by NPK International Inc.